MedPath

Evaluation of effectiveness of betamethasone lotine 0/1% compared with clotrizone lotion (clotrimazole1% and betamethasone 0/05%) in patients with seborrheic dermatitis of face and scalp

Not Applicable
Conditions
Seborrhoeic dermatitis.
Seborrhoeic dermatitis
Registration Number
IRCT2016060628291N1
Lead Sponsor
Vice chancellor for research of Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

patients more than 18 years old with seborrheic dermatitis of face and scalp referred to Quaem and Emam Reza dermatology clinics.

Exclusion Criteria

Patient with systemic disease; Use of topical or systemic treatments of seborrheic dermatitis during 2 previous weeks; Pregnancy and laction; History of allergy to the drugs of this study; HIV infection; Parkinson disease; Using of psyciatric drugs; Other papulo squamus disease (psoriasis, tinea,..).

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of erythema scaling and pruritus. Timepoint: 2 and 4 weeks after beginning of treatment and 4 and 8 weeks after end of treatment period. Method of measurement: Based on measuring the change of amount of erythema scaling and pruritus.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath